P-glycoprotein (P-gp) is an efflux transporter, The efflux of diffused intracellular anticancer medicines is mostly caused by overexpression of P-gp in tumour cells, resulting in low bioavailability of the drug. The gene discussed is PGP; the disease is neoplasm.